Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1785-1788, May 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, S.
Right arrow Articles by Mukhtar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, S.
Right arrow Articles by Mukhtar, H.

Involvement of Nitric Oxide during Phthalocyanine (Pc4) Photodynamic Therapy-mediated Apotosis1

Sanjay Gupta, Nihal Ahmad and Hasan Mukhtar2

Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio 44106

Photodynamic therapy (PDT), a new treatment modality, uses a combination of photosensitizing agent and visible light for the therapy of many solid malignancies. The hallmark of PDT is intracellular oxidative stress mediated by reactive oxygen species, which, through a cascade of events, results in a cell kill that induces apoptosis in some cells. To better understand the mechanism of apoptosis, we hypothesized the role of nitric oxide (NO), which is considered to be involved in a variety of physiological and pathological processes, during PDT. The model photosensitizer we have been working with is a silicon-phthalocyanine compound termed Pc4. Here, we investigated the involvement of NO during Pc4 PDT in PDT of apoptosis-resistant radiation-induced fibrosarcoma (RIF-1) cells and in PDT of apoptosis-sensitive human epidermoid carcinoma (A431) cells. Pc4 PDT resulted in a rapid increase in nitrite production in A431 cells, starting as early as 15 s post-PDT, and showed a progressive increase up to 15 min post-PDT. This increase in nitrite production was observed in cell lysates as well as in the cell culture medium. RIF-1 cells did not show an increase in nitrite production in either the cell lysates or the culture medium. At this time, a majority of the cells were viable. The Western blot analysis also showed a rapid increase in the expression of the constitutive form of NO synthase as early as 15 s post-PDT when compared to that of the controls. This response showed a dose dependency up to 5 min after Pc4 PDT. This observation was confirmed by a [3H]L-citrulline assay, which also showed a similar pattern for constitutive NO-synthase activity. RIF-1 cells did not show any change in protein expression or enzyme activity after the same treatment. These data, for the first time, demonstrate the generation of NO during PDT and suggest that it may be involved in PDT-mediated apoptosis. This may have relevance in improving the therapeutic efficacy of PDT using pharmacological modulators of NO or NO synthase.

1 Supported by USPHS Research Grants R01 CA51802, P01 CA48735, P30 CA43703, and P30 AR39750.

2 To whom requests for reprints should be addressed, at Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106. Phone: (216) 368-1127; Fax: (216) 368-0212; E-mail: hxm4@po.cwru.edu.

Received 2/ 5/98. Accepted 3/19/98.




This article has been cited by other articles:


Home page
IOVSHome page
H. She, T. Nakazawa, A. Matsubara, T. Hisatomi, T. A. Young, N. Michaud, E. Connolly, A. Hafezi-Moghadam, E. S. Gragoudas, and J. W. Miller
Reduced Photoreceptor Damage after Photodynamic Therapy through Blockade of Nitric Oxide Synthase in a Model of Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2268 - 2277.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Z. Renno, F. C. Delori, R. A. Holzer, E. S. Gragoudas, and J. W. Miller
Photodynamic Therapy Using Lu-Tex Induces Apoptosis In Vitro, and Its Effect Is Potentiated by Angiostatin in Retinal Capillary Endothelial Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3963 - 3971.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
C. M. Whitacre, D. K. Feyes, T. Satoh, J. Grossmann, J. W. Mulvihill, H. Mukhtar, and N. L. Oleinick
Photodynamic Therapy with the Phthalocyanine Photosensitizer Pc 4 of SW480 Human Colon Cancer Xenografts in Athymic Mice
Clin. Cancer Res., May 1, 2000; 6(5): 2021 - 2027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Srivastava, N. Ahmad, S. Gupta, and H. Mukhtar
Involvement of Bcl-2 and Bax in Photodynamic Therapy-mediated Apoptosis. ANTISENSE Bcl-2 OLIGONUCLEOTIDE SENSITIZES RIF 1 CELLS TO PHOTODYNAMIC THERAPY APOPTOSIS
J. Biol. Chem., April 27, 2001; 276(18): 15481 - 15488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.